SCHEMBL9181573

SCHEMBL9181573

COc1ccc(C([C]=O)c2cccc(OC)c2OC)cc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
HDAC4 P56524 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
ATM Q13315 1/20 0.39
ACHE P22303 4/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
ODC1 P11926 1/20 0.37
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8911523 0.81 ATM (0.48) CYP1A2ATMACHEL3MBTL1TDP1
SCHEMBL9183859 0.81 CYP1A2 (0.43) CYP1A2CYP1A1CYP1B1HDAC4HDAC8
SCHEMBL9275613 0.78 CYP1A1 (0.43) CYP1A2CYP1A1CYP1B1ATMACHE
SCHEMBL9183864 0.78 ALDH1A1 (0.48) CYP1A2CYP1A1CYP1B1ATMACHE
SCHEMBL8910138 0.73 AOC3 (0.45) HDAC4HDAC8TDP1KMT2AKDM4E
SCHEMBL734007 0.73 ALDH1A1 (0.43) ACHEL3MBTL1KMT2ANPSR1GAA
SCHEMBL6486060 0.70 CA1 (0.50) ACHEL3MBTL1TDP1CA1CA2
SCHEMBL910620 0.70 ACHE (0.50) CYP1A2ACHEL3MBTL1TDP1CA1
SCHEMBL31326058 0.69 IDO1 (0.44) ATMKMT2ANPSR1GAANFE2L2
SCHEMBL9186553 0.69 P4HB (0.44) CYP1A2ACHEKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 EP disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 EP disclosed